Mao Y - Search Results

1

Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma.

Nagarajan D, Parracho RT, Corujo D, Xie M, Kutkaite G, Olsen TK, Rubies Bedos M, Salehi M, Baryawno N, Menden MP, Chen X, Buschbeck M, Mao Y. Nagarajan D, et al. Among authors: mao y. J Clin Invest. 2024 Sep 10;134(21):e175310. doi: 10.1172/JCI175310. J Clin Invest. 2024. PMID: 39255035 Free PMC article.

2

IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.

Tunalı G, Rúbies Bedós M, Nagarajan D, Fridh P, Papakyriacou I, Mao Y. Tunalı G, et al. Among authors: mao y. J Clin Invest. 2023 Apr 3;133(7):e161084. doi: 10.1172/JCI161084. J Clin Invest. 2023. PMID: 36757800 Free PMC article.

3

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer.

Papakyriacou I, Kutkaite G, Rúbies Bedós M, Nagarajan D, Alford LP, Menden MP, Mao Y. Papakyriacou I, et al. Among authors: mao y. Nat Commun. 2024 Apr 27;15(1):3581. doi: 10.1038/s41467-024-47987-x. Nat Commun. 2024. PMID: 38678024 Free PMC article.

4

Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.

Mao Y, Eissler N, Blanc KL, Johnsen JI, Kogner P, Kiessling R. Mao Y, et al. Clin Cancer Res. 2016 Aug 1;22(15):3849-59. doi: 10.1158/1078-0432.CCR-15-1912. Epub 2016 Mar 8. Clin Cancer Res. 2016. PMID: 26957560

5

Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.

Eissler N, Mao Y, Brodin D, Reuterswärd P, Andersson Svahn H, Johnsen JI, Kiessling R, Kogner P. Eissler N, et al. Among authors: mao y. Oncoimmunology. 2016 Sep 9;5(12):e1232222. doi: 10.1080/2162402X.2016.1232222. eCollection 2016. Oncoimmunology. 2016. PMID: 28123870 Free PMC article.

6

Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.

Mao Y, Poschke I, Kiessling R. Mao Y, et al. J Intern Med. 2014 Aug;276(2):154-70. doi: 10.1111/joim.12229. Epub 2014 Mar 24. J Intern Med. 2014. PMID: 24597954 Free article. Review.

7

Myeloid suppressors decrease melanoma survival by abating tumor-fighting T cells.

Kiessling R, Mao Y, Pico de Coaña Y. Kiessling R, et al. Among authors: mao y. Clin Cancer Res. 2014 Mar 15;20(6):1401-3. doi: 10.1158/1078-0432.CCR-13-3388. Epub 2014 Feb 13. Clin Cancer Res. 2014. PMID: 24526737 Review.

8

Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade.

Natoli M, Bonito N, Robinson JD, Ghaem-Maghami S, Mao Y. Natoli M, et al. Among authors: mao y. Cancer Immunol Immunother. 2020 Aug;69(8):1391-1401. doi: 10.1007/s00262-020-02544-5. Epub 2020 Mar 21. Cancer Immunol Immunother. 2020. PMID: 32200422 Free PMC article.

9

Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25⁺ /CD54⁺ NK cells.

Chen Z, Yang Y, Neo SY, Shi H, Chen Y, Wagner AK, Larsson K, Tong L, Jakobsson PJ, Alici E, Wu J, Cao Y, Wang K, Liu LL, Mao Y, Sarhan D, Lundqvist A. Chen Z, et al. Among authors: mao y. EMBO Rep. 2021 Mar 3;22(3):e51329. doi: 10.15252/embr.202051329. Epub 2021 Jan 22. EMBO Rep. 2021. PMID: 33480074 Free PMC article.

10

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.

Wennerberg E, Lundqvist A, Mao Y, Mougiakakos D. Wennerberg E, et al. Among authors: mao y. Front Immunol. 2021 Jul 1;12:718844. doi: 10.3389/fimmu.2021.718844. eCollection 2021. Front Immunol. 2021. PMID: 34276709 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,462 results

Search Page

Filters